What question did this study set out to answer?

To evaluate the outcomes of heart transplantation from DCD donors in recipients who used durable LVADs as a bridge to transplantation.

718 - BJS Prize entrant: the Society of University Surgeons (USA) Prize Winner : durable left ventricular assist device in donation after circulatory death heart transplantation: the United States experience

View Full Paper

Ask AI

Bookmark

Authors

Evaluates 1-year survival rates in DCD heart transplantation recipients with LVADs, suggesting implications for clinical practice.

To evaluate the outcomes of heart transplantation from DCD donors in recipients who used durable LVADs as a bridge to transplantation.
Analyzed UNOS registry data for adult DCD heart transplant recipients from 2019-2023.
Stratified recipients based on the use of durable LVADs as a bridge.
Primary outcome assessed was 1-year post-transplant survival.
703 recipients were analyzed, with 219 (31.2%) using durable LVADs.
1-year survival was lower for recipients with LVADs (88.4%) than without (93.6%).
Status 4 recipients with LVADs showed better survival rates compared to statuses 2 and 3.
HeartMate II and HeartMate 3 recipients had improved survival compared to HeartWare HVAD users.
DCD and DBD recipients with LVADs had similar 1-year survival (88.4% vs. 89.0%).

Hong et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark